• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Yu Shu Tai Victor

    3/27/26 7:08:52 AM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care
    Get the next $MCTA alert in real time by email
    SEC FORM 3SEC Form 3
    FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0104
    Estimated average burden
    hours per response:0.5
    1. Name and Address of Reporting Person*
    YU SHU TAI VICTOR

    (Last)(First)(Middle)
    UNITS 1803-1806, 18/F, HANG LUNG CENTRE
    2-20 PATERSON STREET, CAUSEWAY BAY

    (Street)
    HONG KONG00000

    (City)(State)(Zip)

    HONG KONG

    (Country)
    2. Date of Event Requiring Statement (Month/Day/Year)
    03/18/2026
    3. Issuer Name and Ticker or Trading Symbol
    Charming Medical Ltd [ MCTA ]
    3a. Foreign Trading Symbol
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)Other (specify below)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Yu Shu Tai Victor03/27/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 3: SEC 1473 (03-26)
    Get the next $MCTA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MCTA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MCTA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Yu Shu Tai Victor

    3 - Charming Medical Ltd (0002035992) (Issuer)

    3/27/26 7:08:52 AM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 3 filed by new insider Wong Kit Christine

    3 - Charming Medical Ltd (0002035992) (Issuer)

    3/27/26 7:06:06 AM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 3 filed by new insider Cheung Ching Man

    3 - Charming Medical Ltd (0002035992) (Issuer)

    3/27/26 7:03:37 AM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care

    $MCTA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nasdaq Halts Charming Medical Limited

    NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) --  The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading is halted in Charming Medical Limited (NASDAQ:MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The last sale price of the company's ordinary shares was $29.355.  More information about the SEC's order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104176.pdf. Trading will remain halted until Charming Medical Limited has fully satisfied Nasdaq's request for additional information. For news

    11/26/25 7:00:00 AM ET
    $MCTA
    $NDAQ
    Misc Health and Biotechnology Services
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    Charming Medical Limited Announces Full Exercise of Representative's Over-allotment Option

    HONG KONG, Oct. 28, 2025 /PRNewswire/ -- Charming Medical Limited (NASDAQ:MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced, in connection with its previously announced initial public offering (the "Offering") of 1,600,000 Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares") at a price of $4.00 per share (the "Public Offering Price"), Cathay Securities, Inc., the representative of the underwriters (the "Representative") of the Offering, has exercised its over-allotment option (the "Over-allotment") in full to purchase an additional 240,000 Class A Ordinary Shares at the Publ

    10/28/25 4:15:00 PM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care

    $MCTA
    SEC Filings

    View All

    SEC Form 6-K filed by Charming Medical Limited

    6-K - Charming Medical Ltd (0002035992) (Filer)

    3/31/26 12:29:56 PM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by Charming Medical Limited

    6-K - Charming Medical Ltd (0002035992) (Filer)

    3/27/26 10:44:36 AM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by Charming Medical Limited

    6-K - Charming Medical Ltd (0002035992) (Filer)

    1/6/26 4:01:28 PM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care